Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) is being implemented in most malaria endemic countries as a standard two-doses regimen as it reduces the risk of low birth weight (LBW) and the prevalence of maternal anaemia. Nevertheless, where the risk of infection close to delivery is high because of intense transmission, a third IPTp-SP dose may further reduce the negative effects of malaria on pregnancy outcome. METHODS: Pregnant women in the 2nd or 3rd trimester were randomized to receive either 2 (SP2) or 3 doses (SP3) of SP. Trained field workers paid home visits to the women for drug administration according to a predefined drug delivery schedule. Women were encouraged to attend their scheduled ANC visits and to deliver at the health facilities where the new-born was weighed. The prevalence of LBW (<2500 g), severe anaemia (Hb < 8 g/dL) and premature birth was analysed using intention-to-treat (ITT) and per-protocol (PP) analysis. RESULTS: Data from 1274 singleton pregnancies were analysed (641 in the SP3 and 633 in the SP2 group). The uptake of the intervention appeared to be low. Though the prevalence of LBW in both intervention groups was similar (adjusted Incident Rate Ratio, AIRR = 0.92, 95%CI: 0.69-1.24) in the ITT analysis, the risk of severe anaemia was significantly lower in the SP3 group compared to the SP2 group (AIRR = 0.38, 95%CI: 0.16 - 0.90). The PP analysis showed a trend of reduced risk of LBW, severe anaemia and premature delivery in the SP3 group, albeit the difference between two and three IPTp-SP did not reach statistical significance. CONCLUSION: The risk of LBW and severe anaemia tended to be lower in the SP3 group, though this was not statistically significant, probably due to the low uptake of the intervention which reduced the power of the study. Further studies are needed for establishing whether a third SP dose has a real benefit in preventing the negative effects of malaria in pregnancy in settings where transmission is markedly seasonal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa
Guyatt, H. L., & Snow, R. W. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.760-769.2004 · Cited by 458
Kayentao, K., Kodio, M., Newman, R. D., Maiga, H., Doumtabe, D., Ongoiba, A., Coulibaly, D., Keita, A. S., Maiga, B., Mungai, M., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/426400 · Cited by 162 · cited 1×
“The latter may be beneficial also where malaria transmission is markedly seasonal as women receiving the second IPTp-SP dose more than one month before delivery can still be re-infected [14].”
BackgroundFiller, S. J., Kazembe, P., Thigpen, M., Macheso, A., Parise, M. E., Newman, R. D., Steketee, R. W., & Hamel, M. (2006) · The Journal of Infectious Diseases · doi:10.1086/505080 · Cited by 108
Brabin, B. J., Ginny, M., Alpers, M., Brabin, L., Eggelte, T., & Van Der Kaay, H. J. (1990) · Annals of Tropical Medicine & Parasitology · doi:10.1080/00034983.1990.11812428 · Cited by 58
Gies, S., Coulibaly, S. O., Ouattara, F. T., & D’Alessandro, U. (2009) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02215.x · Cited by 47 · cited 2×
“Indeed, in a study on the effectiveness of IPTp-SP carried out in Burkina Faso, in a similar setting, the impact of two IPTp-SP doses as compared to one or none was more marked in primigravidae than in secundigravidae [17].”
BackgroundResultSelf-citationMalaria Burden Among Pregnant Women Living in the Rural District of Boromo, Burkina Faso
Coulibaly, S. O., Gies, S., & D’Alessandro, U. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.56 · Cited by 42 · cited 1×
“Malaria is holo-endemic with marked seasonal (June - December) transmission [19].”
BackgroundSelf-citation
Cited by
Kayentao, K., Garner, P., Maria van Eijk, A., Naidoo, I., Roper, C., Mulokozi, A., MacArthur, J. R., Luntamo, M., Ashorn, P., Doumbo, O. K., et al. (2013) · JAMA · doi:10.1001/jama.2012.216231 · Cited by 298
Moore, K. A., Simpson, J. A., Scoullar, M. J. L., McGready, R., & Fowkes, F. J. I. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30340-6 · Cited by 165
the FSP/MISAME study Group, Valea, I., Tinto, H., Drabo, M. K., Huybregts, L., Sorgho, H., Ouedraogo, J.-B., Guiguemde, R. T., van Geertruyden, J. P., Kolsteren, P., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-71 · Cited by 87
“Characteristics of study participants according to randomization groups were published elsewhere [23].”
BackgroundResultSelf-citationDosoo, D. K., Chandramohan, D., Atibilla, D., Oppong, F. B., Ankrah, L., Kayan, K., Agyemang, V., Adu-Gyasi, D., Twumasi, M., Amenga-Etego, S., et al. (2020) · Malaria Journal · doi:10.1186/s12936-020-03457-5 · Cited by 63
Metadata
- Authors
- the FSP/MISAME study Group, Valea, I., Tinto, H., Drabo, M. K., Huybregts, L., Henry, M.-C., Roberfroid, D., Guiguemde, R. T., Kolsteren, P., & D'Alessandro, U.
- Venue
- Malaria Journal
- Published
- 2010-11-12
- Volume
- 9
- Issue
- 1
- Pages
- 324-324
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2166773458
- Cited by
- 24
- References
- 8
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.